Maternal Tryptophan and Kynurenine Pathway Metabolites and Risk of

Share "Maternal Tryptophan and Kynurenine Pathway Metabolites and Risk of"

N/A

Protected

Studieår: 2022

Info

Nedlasting

Protected

Academic year: 2022

Share "Maternal Tryptophan and Kynurenine Pathway Metabolites and Risk of"

Copied!

Laster.... (Se fulltekst nå)

Last ned nå ( 8 sider )

Fulltekst

Referanser

Last ned nå ( PDF - 8 sider - 302.08 KB )

RELATERTE DOKUMENTER

Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes

MMc was estimated as maternal DNA quantity in the fetal circulation, by NIMA specific ddPCR, measured in cord blood DNA from 71 children who later developed T1D and 126

RELATERTE DOKUMENTER

The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites

RESEARCH ARTICLE

Kynurenine Pathway Metabolites in Alzheimer’s Disease

Associations between intake of fish and n‑3 long‑chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease

A prospective study of pre-diagnostic circulating tryptophan and kynurenine, and the kynurenine/tryptophan ratio and risk of glioma

Alterations in the Kynurenine Pathway of Tryptophan Metabolism Are Associated With Depression in People

Maternal plasma total neopterin and kynurenine/ tryptophan levels during pregnancy in relation to asthma development in the offspring

Interferon (IFN)- γ -mediated inﬂammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study